Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 20 to 24, 2021. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 20 to 24, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Guillain-Barré Syndrome May Be Triggered by SARS-CoV-2 Infection
FRIDAY, Sept. 24, 2021 (HealthDay News) — Within a series of Guillain-Barré syndrome patients, 22 percent had confirmed or probable severe acute respiratory syndrome coronavirus 2 infection, according to a study published online Sept. 23 in Brain.
WHO Issues Guidance for Use of Casirivimab-Imdevimab in COVID-19
FRIDAY, Sept. 24, 2021 (HealthDay News) — Use of two recombinant human monoclonal antibodies that bind to the severe acute respiratory syndrome coronavirus 2 spike protein, casirivimab and imdevimab, is conditionally recommended for patients with nonsevere disease at highest risk for severe disease and for severe and critical infection among seronegative patients, according to a living guideline published online Sept. 24 in The BMJ.
CDC Endorses Booster Shots for Millions of Americans
FRIDAY, Sept. 24, 2021 (HealthDay News) — The U.S. Centers for Disease Control and Prevention on Thursday recommended booster shots of the Pfizer COVID-19 vaccine for millions of older and high-risk Americans, kicking off a new chapter in the national effort to protect the vulnerable from severe disease.
Antibodies ID’d in Neonates of Women Vaccinated Against COVID-19
FRIDAY, Sept. 24, 2021 (HealthDay News) — Neonates born to women vaccinated against COVID-19 during pregnancy have high levels of antibodies to the spike protein, according to a study published online Sept. 22 in the American Journal of Obstetrics & Gynecology: Maternal-Fetal Medicine.
Past Trauma Tied to Worse Mental Health During Pandemic for Aging Women
FRIDAY, Sept. 24, 2021 (HealthDay News) — Aging women with a history of childhood abuse or intimate partner violence have reported worse mental health, sleep, and conflict during the COVID-19 pandemic compared with women without these adverse experiences, according to a study presented at the annual meeting of the North American Menopause Society, held from Sept. 22 to 25 in Washington, D.C.
FDA Approves Pfizer Booster Shots for Seniors, High-Risk Americans
THURSDAY, Sept. 23, 2021 (HealthDay News) — The U.S. Food and Drug Administration on Wednesday approved Pfizer COVID-19 vaccine booster shots for people older than 65 years and for those at high risk for severe COVID-19. Under the emergency use authorization, the booster shots should be given at least six months after a person is fully vaccinated.
Emergency Help for Suicide-Related Issues Up During Pandemic for Some Youth
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
Trends Reported in Vaccination Coverage for Adolescents for 2025 
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer 
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens 
Social Media Warnings Could Discourage Use Among Teens, Young Adults 
Digital Behavioral Health Game Reduces Depressive Symptoms in Teens .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
Reinitiating Obesity Meds After Bariatric Surgery Tied to Greater One-Year Weight Loss in Youths 
.jpeg)
